Chris E. Lawrence
Impact in
-
- Chemokine receptors and signaling
-
- Microtubule and mitosis dynamics
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 4
- Co-authors
- Jonathan Zalevsky (4 shared papers)Sher Karki (3 shared papers)Seung Y. Chu (3 shared papers)John R. Desjarlais (3 shared papers)David F. Carmichael (3 shared papers)Eugene A. Zhukovsky (2 shared papers)Irene Leung (2 shared papers)Vladimir Vainstein (3 shared papers)
- Journals
- Blood (6 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Cancer Research (1 paper)BMC Cancer (1 paper)Experimental Hematology and Oncology (1 paper)
- Partner nations
- United States
In The Last Decade
Chris E. Lawrence
13 papers receiving 330 citations
Peers
Comparison fields: 5 of 45
- Oncology 80
- Cell Biology 40
- Radiology, Nuclear Medicine and Imaging 59
- Immunology 34
- Pathology and Forensic Medicine 28
Countries citing papers authored by Chris E. Lawrence
This map shows the geographic impact of Chris E. Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris E. Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris E. Lawrence more than expected).
Fields of papers citing papers by Chris E. Lawrence
This network shows the impact of papers produced by Chris E. Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris E. Lawrence. The network helps show where Chris E. Lawrence may publish in the future.
Co-authors
The 25 scholars most cited alongside Chris E. Lawrence, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 95 | |
| 2 | 2007 | 92 | |
| 3 | 2008 | 75 | |
| 4 | 2014 | 25 | |
| 5 | 2016 | 17 | |
| 6 | 2014 | 14 | |
| 7 | 2010 | 13 | |
| 8 | 2007 | 8 | |
| 9 | 2008 | 8 | |
| 10 | 2016 | 6 | |
| 11 | SNS-595, a novel S-phase active cytotoxic, exhibits potent in vitro and in vivo activities, and has the potential for treating advanced hematologic malignancies | 2006 | 1 |
| 12 | 2008 | 1 | |
| 13 | 2013 | 1 |
About Chris E. Lawrence
Chris E. Lawrence is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Oncology, Immunology and Allergy and Gastroenterology, having authored 13 papers that have together received 356 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Microtubule and mitosis dynamics (1 paper), Cancer therapeutics and mechanisms (1 paper), Acute Myeloid Leukemia Research (1 paper), Gastrointestinal motility and disorders (1 paper), Cell Adhesion Molecules Research (1 paper), Glioma Diagnosis and Treatment (1 paper) and Musculoskeletal pain and rehabilitation (1 paper). The work is most often cited by research in Oncology (80 citations), Cell Biology (40 citations), Radiology, Nuclear Medicine and Imaging (59 citations), Immunology (34 citations) and Pathology and Forensic Medicine (28 citations). Chris E. Lawrence has collaborated with scholars based in United States. Frequent co-authors include Jonathan Zalevsky, Sher Karki, Seung Y. Chu, John R. Desjarlais, David F. Carmichael, Eugene A. Zhukovsky, Irene Leung, Vladimir Vainstein, Olga Brawman‐Mintzer and Zoya Gluzman‐Poltorak. Their work appears in journals such as Blood, Bioorganic & Medicinal Chemistry Letters, Cancer Research, BMC Cancer and Experimental Hematology and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.